Sepsis

FDA grants breakthrough device designation to MeMed sepsis test
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to MeMed for its rapid diagnostic and risk assessment test for sepsis.
December 12, 2024
Fda Sign Dc Social
T2 Biosystems to license pathogen-detection technology
By LabPulse.com staff writers
T2 Biosystems plans to license its proprietary technology for the detection of sepsis-causing pathogens from whole blood.
December 9, 2024
Bacteria Blood Sepsis Social
Abionic sepsis test gets FDA 510(k) clearance
By LabPulse.com staff writers
Abionic, a diagnostics firm specializing in rapid early detection, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IVD Capsule PSP test for sepsis.
October 3, 2024
Fda Button Social
BioMérieux receives 510(k) certification for antimicrobial testing system
By LabPulse.com staff writers
BioMérieux has received 510(k) clearance from the U.S. Food and Drug Administration for its Vitek Reveal AST system, which reports antimicrobial susceptibility testing (AST) results directly from positive blood cultures.
August 21, 2024
Sepsis Bacteria Social
Accelerate Diagnostics completes preclinical trial for antimicrobial test system
By LabPulse.com staff writers
Accelerate Diagnostics successfully completed the preclinical trial of its WAVE antimicrobial susceptibility testing system.
August 12, 2024
Bacteria Blood Sepsis Social
Researchers map protein biomarkers in sepsis fight
By Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
Sepsis Bacteria Social
Cytokine improves outcomes in mice with sepsis, predicts survival in humans
By Nick Paul Taylor
Administering a protein that correlates to survival in sepsis has improved survival in mice in a study, pointing to a potential new way to treat the life-threatening reaction to infection.
February 6, 2024
Antigen Tcell Cytokines Social
Program to fight sepsis in LMICs launched at SCCM Congress, test data presented
By Matt Limb
Intensive care professionals have unveiled a program to cut deaths from sepsis in low- and middle-income countries (LMICs) with ambitions to improve access to diagnostic tools, laboratories, and medicines.
January 26, 2024
Sepsis Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
By LabPulse.com staff writers
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Sepsis Bacteria Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
By Matt Limb
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Bacteria Blood Sepsis Social
Cytovale raises $84M in series C funding
By LabPulse.com staff writers
Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.
November 16, 2023
Money Hundred Bills Social
Some emergency sepsis screening tools inadequate, EU study suggests
By Matt Limb
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Sepsis Bacteria Social
Page 1 of 6
Next Page